Logo image
Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma
Journal article   Open access   Peer reviewed

Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma

Mengjun Wang, Ronald E Long, Mary Ann Comunale, Omer Junaidi, Jorge Marrero, Adrian M Di Bisceglie, Timothy M Block and Anand S Mehta
Cancer epidemiology, biomarkers & prevention, v 18(6), pp 1914-1921
Jun 2009
PMID: 19454616
url
https://doi.org/10.1158/1055-9965.EPI-08-0980View
Published, Version of Record (VoR) Open

Abstract

Area Under Curve Early Detection of Cancer Humans Male Glycosylation Blotting, Western Biomarkers, Tumor - blood Liver Neoplasms - blood Sensitivity and Specificity Carcinoma, Hepatocellular - pathology Liver Neoplasms - metabolism Immunoassay - methods Female Liver Neoplasms - pathology ROC Curve Kininogens - metabolism alpha 1-Antitrypsin - metabolism Carcinoma, Hepatocellular - blood Neoplasm Staging Carcinoma, Hepatocellular - metabolism
Changes in glycosylation, most notably fucosylation, have been associated with the development of hepatocellular carcinoma (HCC). In this report, the levels of fucosylated kininogen (Fc-Kin) and fucosylated alpha-1-antitrypsin were analyzed individually and in combination with the currently used marker, alpha-fetoprotein, and a previously identified biomarker, Golgi protein 73 (GP73), for the ability to distinguish between a diagnosis of cirrhosis and HCC. This analysis was done on serum from 113 patients with cirrhosis and 164 serum samples from patients with cirrhosis plus HCC. The levels of Fc-Kin and fucosylated alpha-1-antitrypsin were significantly higher in patients with HCC compared with those with cirrhosis (P < 0.0001). Greatest performance was achieved through the combination of Fc-Kin, alpha-fetoprotein, and GP73, giving an optimal sensitivity of 95%, a specificity of 70%, and an area under the receiver operating characteristic of 0.94. In conclusion, the altered glycosylation of serum glycoproteins can act as potential biomarkers of primary HCC when used independently or in combination with other markers of HCC.

Metrics

14 Record Views
148 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Oncology
Public, Environmental & Occupational Health
Logo image